What is TTNS, and why is bladder function treated through the ankle?
If you need to go to the toilet frequently, get a sudden, urgent need to urinate, wake several times at night because of it, or sometimes cannot reach the toilet in time, you have probably already heard about medication and pelvic floor exercises.
TTNS is a third option that is discussed much less, even though it can be done comfortably at home. The abbreviation stands for transcutaneous tibial nerve stimulation: stimulating the tibial nerve (nervus tibialis), which runs along the inner side of the ankle, through the skin with a low electrical current. Two self-adhesive electrodes are placed on the ankle, and the device sends gentle, barely perceptible electrical impulses.
At first, it may seem surprising that we approach bladder symptoms from the ankle. The explanation lies in the anatomy: the tibial nerve originates from the same spinal cord segments (L4–S3) as the nerve control of the bladder. The impulse travelling upwards along the nerve reaches the sacral voiding centre, where it may quieten the overactive reflex that causes a sudden, compelling urge to urinate.
Key point
TTNS does not treat the bladder itself. It targets the faulty nerve regulation behind the problem. It is painless, non-invasive and does not require needles – which is why it can also be done at home. The effect does not come from a single treatment, however, but from regular repetition.
How does it work?
It is useful to imagine what happens in your body during treatment in three simple steps.
The electrode is placed on your ankle over a thin bundle of nerves. The device's impulses stimulate this nerve – but not downwards towards the foot. They travel backwards and upwards, towards the spinal cord. This is why it is called retrograde stimulation.
The fibres of the tibial nerve enter the same spinal cord segments where the nerve cells that regulate bladder function are located. The impulse therefore arrives exactly where the bladder's “control panel” is.
With an overactive bladder, the bladder muscle (detrusor) contracts even when there is still plenty of room in the bladder. This is why a sudden, urgent need to urinate can occur even with a partly empty bladder.
Repeated nerve stimulation may slow this oversensitive reflex circuit: at spinal cord level, it changes the balance between the bladder's “wait a little longer” and “I cannot hold on any more” signals. The medical literature calls this neuromodulation – not switching the system off, but re-regulating it.
This is the most important sentence in the article: a single treatment does not produce any lasting change on its own.
The nervous system behaves much like a muscle. Nobody becomes stronger after one workout – change comes from repeated loading over weeks and months. Re-regulating nerve reflexes works in the same way: the trace of the impulse remains faint, and only becomes established when it arrives again and again.
This is why studies in the medical literature measure TTNS results after 6–12 weeks of regular treatment – and why the effect gradually fades when treatment stops.
What does a treatment involve in practice?
The treatment is surprisingly simple – this section explains how it works. Sit comfortably and support your leg. Clean the skin on your ankle so that it is dry and free of grease, then apply the two self-adhesive electrodes:
| Electrode | Where is it placed? |
|---|---|
| First (active) | Behind and slightly above the medial ankle – approximately two or three finger-widths above the bony prominence of the ankle, over the path of the nerve |
| Second | On the same line, approximately 8–10 cm higher up the lower leg |
Then all you need to do is select the tibial nerve stimulation programme from the device menu and start it. Slowly increase the intensity until you feel a comfortable tingling and your big toe just twitches or bends – this indicates that the electrode is in the right place. It should not hurt.
Treatment usually lasts 30 minutes, once a day. You can read, watch television or work during it.
You do not need to set the parameters
Many people are put off by the references to frequency, pulse duration and milliamps in professional articles. You do not need to deal with these. The treatment programmes in medical devices are preset by the manufacturer's specialists according to professional protocols – precisely so that users do not have to make technical decisions.
Your task is simply this: apply the electrodes, select the TTNS programme from the menu, start it and set an intensity that feels comfortable. Nothing else.
Why are a few treatments received in hospital not enough?
This is where most treatment courses get stuck – and where most disappointment begins.
If you are admitted to a urology or rehabilitation department, or attend an outpatient clinic, you will quite likely receive a few stimulation treatments. This is the professionally correct first step: it shows whether you tolerate the method well and whether it is suitable for you. But it is not enough as a treatment course. Not because it is being done incorrectly, but because the dose is insufficient.
Think about how the body actually works. Muscles – including the pelvic floor muscles – change only in response to regular contractions, in other words regular training. Someone who lifts weights five times in their life will not become stronger. Re-regulating nerve reflexes is no different: repetition, repetition, repetition.
This is why studies use treatment courses lasting 6–12 weeks and then recommend maintenance treatments. Realistically, you should therefore plan for at least 2–3 months of regular treatment – not just a few days.
This treatment volume cannot be managed in an institution
Not because they do not want to. But because:
- You cannot travel there every day. Someone who works, or an older person with limited mobility, cannot go to the clinic every single day, take a number and wait their turn – for months.
- Social insurance does not fund this much. Funding covers a few appointments, not five to seven treatments a week for a quarter of a year.
- Institutions have limited capacity. If every affected patient attended daily for three months, the service would collapse.
The conclusion is not that hospital treatment is unnecessary – it is that it can be started there, but it must be completed at home.
We know the same logic from other areas. A one-week course of physiotherapy will not put your back right; daily exercises over six months can. The situation is exactly the same with electrotherapy – and this is precisely why medical devices for home use were developed.
Home treatment – what do you need?
To complete the 2–3-month treatment course, you need a device that includes a factory TTNS programme. This matters: a general muscle stimulator does not have this programme, and you should not have to assemble the parameters yourself.
TensCare Sure Pro incontinence stimulator
This CE-marked medical device was developed specifically for the home treatment of urinary incontinence symptoms. Its menu includes dedicated tibial nerve stimulation (TIBN) programmes – select one, start it, and the device works according to the built-in professional protocol.
It also includes urgency (URGE), stress (STRE) and mixed incontinence programmes, as well as pelvic floor training programmes, so your treating doctor can tailor the treatment to the type of symptoms you have. Two independent channels, 99 intensity levels with fine adjustment and a rechargeable battery.
My advice when choosing
Before buying a device, discuss with your treating doctor which programme is suitable for your symptoms. At the end of the article, you will find a summary that you can print or show on your phone and take to your doctor – so they can understand the situation in a few minutes.
Before starting treatment
Studies indicate that TTNS is generally well tolerated. No serious side effects have been reported in research, at most mild skin redness or an unpleasant sensation under the electrode. In some situations, however, it should not be used, or should only be used under medical supervision.
When should you not start, or when should you ask your doctor first?
- Implanted cardiac pacemaker or defibrillator – an electrical stimulator must not be used without medical approval in this situation.
- Pregnancy – the safety of electrotherapy during pregnancy has not been established, so it is not recommended.
- Damaged, inflamed or infected skin at the electrode site – electrodes may only be applied to intact skin.
- Deep vein thrombosis of the lower limb or suspected thrombosis – stimulation must not be applied to the affected limb.
- Reduced sensation in the leg (for example, diabetic neuropathy) – if you cannot reliably feel the current, you cannot set the intensity safely; use only under medical guidance.
- Epilepsy – increased caution and prior medical consultation are required.
- Urinary symptoms of unclear origin – if there is blood in the urine, pain, fever or a sudden onset of symptoms, the underlying cause must be investigated first.
Important information
The home device is intended to complement the treatment recommended by your doctor, not to replace it. Before starting treatment, the cause of your symptoms must always be investigated – less commonly, another condition may be behind the symptoms of an overactive bladder.
What does the research say?
“Can this really help me, or is it just a placebo?”
The latest comprehensive analysis, which compared data from more than forty publications and almost three thousand participants, found that regularly applied TTNS may measurably reduce the number of urinary leakage episodes, urinary urgency and night-time urination. No study reported serious side effects – at most mild discomfort.1
Not every study was positive: one, for example, found no difference compared with sham treatment.4 The method is therefore promising, but it does not work for everyone – it is worth starting with realistic expectations.
“Why is it not enough to do it only a few times?”
Because the results of the studies all come from treatment series. In clinical research, treatment was typically given two or three times a week for 6–12 weeks, or daily using a home device. Review articles also repeatedly point out that the effect gradually fades after treatment stops, so maintenance treatment is needed.2 5
“Is home treatment just as good as treatment with a needle in the clinic?”
The needled version (PTNS) is a clinic-based treatment using a needle electrode. Reviews comparing the two methods suggest that their effectiveness is broadly similar, while patients find the surface-based, needle-free version more comfortable – an important consideration during a long treatment series, because it affects whether someone completes the course.
Daily treatment at home with a personal device has also been studied separately: participants tolerated it well, and instrumental measures of bladder function also improved over four weeks.3
“I also have a neurological condition – could it be suitable for me?”
The method has also been studied in multiple sclerosis and other neurological conditions. In a larger patient group, bladder symptoms and daily voiding diary measures improved, and a substantial proportion of participants were satisfied with the result. In such cases, treatment should definitely be planned together with your neurologist or urologist.7 Related reading: multiple sclerosis and home therapy.
Practical advice for the 2–3-month treatment
The most common reason for failure is not the method, but stopping. A few things that may help you complete the course:
- Make it part of your routine. Always do it at the same time – for example, while watching the evening news or a film. Something that requires a separate decision will sooner or later be skipped.
- Keep a voiding diary. Record how many times you went to the toilet and how often you had an urgent need to urinate. Without this, it is difficult to judge whether anything is changing, because improvement is gradual.
- Do not expect quick results. Differences began to appear in studies after 4–6 weeks. Do not draw conclusions during the first two weeks. This timeframe relates to clinical studies; effective treatment may require more time.
- Look after the electrodes. Put them back on the protective film after use and store them in a cool place. A dried-out electrode conducts poorly, may sting and reduces the effectiveness of treatment.
- Think about maintenance. If you notice improvement at the end of the course, discuss with your doctor how often you should continue – maintaining the effect usually requires treatment less often, but on a regular basis.
My advice
Do not stop pelvic floor exercises while using stimulation. The two methods are not competitors: TTNS targets nerve regulation, while the exercises train the muscles. Together, they may achieve more than either method alone – and you do not need any equipment for the exercises.
Information for your doctor
I wrote the following summary so that you have something to show your doctor. It briefly sets out, in professional language, everything they need to decide within a few minutes whether to recommend the method for you. Open it and show it to them – or print it and take it with you.
Mechanism of action: the afferent fibres of the posterior tibial nerve run into the L4–S3 segments, where the sacral voiding centre (S2–S4) is also located. Retrograde, ascending stimulation modulates the reflex circuit of detrusor overactivity at spinal and supraspinal levels – so this is neuromodulation, not muscle stimulation.
Indications studied: idiopathic overactive bladder (OAB dry and wet), neurogenic bladder dysfunction (multiple sclerosis, Parkinson's disease, stroke, spinal cord injury), urgency and mixed incontinence, and nocturia. It has also been studied as a combination treatment for OAB associated with BPH.
Place in treatment: a conservative, second-line option – alongside behavioural therapy and pelvic floor training, or as an alternative or adjunct to antimuscarinic/beta-3 agonist treatment, particularly where the anticholinergic side-effect profile (dry mouth, constipation, cognitive burden in older patients) is a limiting factor.
Current type: TENS-like, sensory-level neuromodulatory stimulus – not NMES/EMS. Any toe movement is not a therapeutic goal, but feedback on electrode position and intensity. Continuous mode, not burst and not modulated.
Waveform: rectangular pulse, biphasic for transcutaneous application, with zero net direct-current component – this helps prevent electrochemical skin irritation under the electrode during long sessions. (It should be noted that most publications do not report the waveform.)
| Parameter | Usual value |
|---|---|
| Frequency | 10 Hz or 20 Hz |
| Pulse duration | 200 µs (in the vast majority of studies) |
| Intensity | to the sensory threshold, or to the motor threshold (visible toe flexion), below the pain threshold |
| Session length | 30 minutes (60 minutes in some protocols) |
| Frequency | 2–3 times weekly, or once daily with a home device |
| Course length | 6–12 weeks, followed by maintenance treatment |
Electrode position: the active electrode behind and above the medial malleolus, over the course of the nerve; the second electrode on the same line, 8–10 cm more proximally. Treatment is generally unilateral.
Parameter selection: according to the 2025 meta-analysis, 10 Hz is more favourable for incontinence episodes, while intensity raised to the motor threshold is more favourable for urgency and nocturia.1 Factory TTNS programmes in home medical devices contain these protocol values, so the patient does not need to set the parameters.
Supporting evidence: the 2025 systematic review and meta-analysis processed data from 42 publications, 13 randomised studies and 2715 participants, with a low risk of bias; the 10 Hz protocol showed meaningful improvement in incontinence episodes, while the motor threshold improved urgency and nocturia.1 Reviews comparing TTNS with PTNS found near-equivalent effectiveness, with better comfort for the transcutaneous version.5 In a medication-naive patient group, the response rate was higher than in the medication-resistant group.6
Limitations: protocol heterogeneity is a recurring criticism in all reviews – frequency, intensity setting, number of sessions and course length vary between studies, which limits generalisability.2 A double-blind, sham-controlled randomised study (n=50, OAB and neurogenic bladder) found no difference between active and sham treatment.4 A meta-analysis of neurogenic bladder found a confirmed benefit for nocturia episodes, but not for OAB symptom scores.8
Safety: no study reported a serious adverse event; reported events were mild local discomfort and skin reactions.1
The effect is dose-dependent and cumulative: published results come from 6–12-week treatment series given 2–3 times weekly or daily, and the effect fades after treatment is suspended. This treatment volume cannot realistically be provided in an institutional setting because of the patient's travel burden, clinic capacity and funding limits.
The transcutaneous technique is therefore particularly suitable for self-treatment at home: there is no needle puncture, electrode placement can be reproduced reliably after brief instruction, and the factory TTNS programmes in CE-marked home devices contain the protocol parameters. A separate study also confirmed the feasibility and tolerability of daily treatment with a home TTNS device, with urodynamic monitoring.3 Clinic-based treatment can therefore be limited to starting the course, providing instruction and follow-up, while maintenance treatment takes place at home.
Recommended patient follow-up: voiding diary at baseline and after 6 weeks; in non-responders, adjustment of the parameter (10 vs. 20 Hz) or intensity setting (sensory vs. motor threshold), or reconsideration of the treatment.
Frequently asked questions
No. You should feel a pleasant tingling around the ankle and sole, possibly with slight toe movement. If it stings or hurts, the intensity is too high or the electrode has dried out – turn it down or replace the electrode.
In studies, differences typically began to appear after 4–6 weeks of regular treatment. Do not draw conclusions during the first two weeks. Realistically, plan for 2–3 months of treatment and expect maintenance treatment afterwards.
No. The treatment programmes in medical devices are created and preset at the factory according to professional protocols. All you need to do is apply the electrodes, select the TTNS programme from the menu, start it and set an intensity that feels comfortable.
Most studies used one-sided treatment – generally, it does not matter which side you choose, but it is worth using the same side throughout. If your doctor recommends otherwise, follow their guidance.
You need to discuss this with your doctor. It has also been studied in combination, and combined treatment produced more favourable results than medication alone. Do not stop your medication on your own.
No. Pelvic floor stimulation trains the muscles, while TTNS targets nerve regulation through the ankle. The two approaches can complement each other well – many devices, such as the Sure Pro, include both types of programme.
Summary – Quick overview
Sources
- Vaca-Benavides DA, Ju W, Gonzalez C, et al. (2025). The importance of electrical parameters on transcutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Age and Ageing. PubMed: 40711757
- Sayner AM, Rogers F, Tran J, et al. (2022). Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review. Neuromodulation. PubMed: 35688702
- Li X, Li X, Zhou Z, Zhao H, Liao L. (2022). Feasibility of a Transcutaneous Tibial Nerve Stimulation Device Use in Overactive Bladder Patients. Frontiers in Neurology. PubMed: 35528738
- Welk B, McKibbon M. (2020). A randomized, controlled trial of transcutaneous tibial nerve stimulation to treat overactive bladder and neurogenic bladder patients. Canadian Urological Association Journal. PubMed: 32017693
- Agost-González A, Escobio-Prieto I, Pareja-Leal AM, et al. (2021). Percutaneous versus Transcutaneous Electrical Stimulation of the Posterior Tibial Nerve in Idiopathic Overactive Bladder Syndrome with Urinary Incontinence in Adults: A Systematic Review. Healthcare (Basel). PubMed: 34356261
- Yildiz N, Celtek MA. (2024). Effects of Transcutaneous Tibial Nerve Stimulation in Women Refractory to and Never Used Pharmacological Agents for Idiopathic Overactive Bladder. International Urogynecology Journal. PubMed: 38206337
- Hentzen C, Chesnel C, Lagnau P, et al. (2024). Transcutaneous tibial nerve stimulation in patients with multiple sclerosis and overactive bladder: a real-life clinical and urodynamic assessment. World Journal of Urology. PubMed: 38478090
- Bapir R, Bhatti KH, Eliwa A, et al. (2022). Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials. Archivio Italiano di Urologia e Andrologia. PubMed: 36576454
